Please login to the form below

Not currently logged in
Email:
Password:

MDR

This page shows the latest MDR news and features for those working in and with pharma, biotech and healthcare.

FDA green lights study of phage-based drug for resistant infections

FDA green lights study of phage-based drug for resistant infections

One company working in this area – Adaptive Phage Therapeutics – has just won FDA approval to start human testing of personalised bacteriophage therapeutics for serious MDR infections. ... strain. Arms of the study will also focus on specific bacteria

Latest news

More from news
Approximately 4 fully matching, plus 27 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Will most electronic consumer goods turn into medical devices after the MDR? Will most electronic consumer goods turn into medical devices after the MDR?

    Whilst waiting for more concise guidance from the European Commission, it is left to our own interpretation as to how far the Medical Device Regulation (MDR) will go when it comes ... Under the MDR that kicked-off in May this year, a medical device

  • Medical Device Clinical Trials 2020 Medical Device Clinical Trials 2020

    In this session, we heard from Bassil Akra, CEO of QUnique Group, who gave us a quick overview of the EU MDR. ... We’re pleased to hear that not only the pharma industry will benefit from the EU MDR, but there will be positive changes for patients too.

  • Hanover Communications Hanover Communications

    Will most electronic consumer goods turn into medical devices after the MDR?.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...